Encore Medical IPO Priced at $5 for a $15 Million NYSE American Debut
As seen on the 24/7 Wall St. homepage on August 10, 2026.
Price fixed at $5 flat, no range, $15M deal
Seven amendments in, Encore Medical has settled on a flat $5 per share for 3 million shares, a $15 million raise headed for NYSE American. A deal that small, with Oak Ridge Financial and Network 1 Financial running the books, means thin float and violent first-day pricing.
Continue ReadingShow less
Encore Medical, Inc. has filed its seventh amendment to its IPO prospectus, locking in a fixed price of $5 per share on 3 million shares — a structure that bypasses the traditional range entirely and sets a firm $15 million raise as the target. The deal is set to list on NYSE American under the proposed ticker EMI.
At $15 million, this is a micro-cap offering by any standard, and the combination of a small share count and a fixed price tends to leave very little stock in public hands on day one. A thin float like this can produce outsized swings in both directions as opening-day demand meets limited supply, making the first hours of trading particularly unpredictable.
Oak Ridge Financial and Network 1 Financial are co-managing the books. Both firms are known for smaller growth-company deals rather than large institutional roadshows, which shapes the likely investor base and reinforces expectations of concentrated, volatile early trading rather than the steadier price discovery that accompanies larger, more broadly distributed offerings.
Mentioned: EMI